Angiotensin converting enzyme gene insertion/deletion polymorphism: case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia

Am J Med Genet. 2002 Apr 8;114(3):310-4. doi: 10.1002/ajmg.10255.

Abstract

Angiotensin converting enzyme (ACE) is a candidate gene for psychiatric disorders. We examined the frequency of a functional insertion/deletion (I/D) polymorphism in the 16th intron of the ACE gene (located on chromosome 17q23) in groups of patients with schizophrenia (n = 104 and 113), major depression (n = 55), and bipolar disorder (n = 87) compared to healthy control subjects (n = 87). There was no evidence for allelic or genotypic association of the polymorphism with any of the disorders or with tardive dyskinesia (TD) in patients with schizophrenia. In a sample of nuclear families (n = 61) made up of one or more patients with schizophrenia recruited with their parents, there was no evidence for biased transmission of ACE I/D alleles. Particularly in the case of schizophrenia, these findings do not support an association of the ACE I/D polymorphism with the phenotypes examined.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Case-Control Studies
  • DNA / genetics
  • Dyskinesia, Drug-Induced / enzymology
  • Dyskinesia, Drug-Induced / genetics*
  • Family Health
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Male
  • Mood Disorders / enzymology
  • Mood Disorders / genetics*
  • Mutagenesis, Insertional
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic
  • Schizophrenia / enzymology
  • Schizophrenia / genetics*
  • Sequence Deletion

Substances

  • DNA
  • Peptidyl-Dipeptidase A